Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on: June 12,2024

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Updated on:June 12,2024

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on: July 11,2024

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on:July 11,2024

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on: July 19,2024

Research team explores etiologies of splenic venous hypertension

by Xia & He Publishing Inc.(A) Compression. Pancreatic cysts compress the splenic vein, increasing venous flow in the gastric veins and forming varices. Other causes of compression include pancrea

Updated on:July 19,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on: June 01,2024

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on:June 01,2024

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro

Updated on: May 28,2024

Assessing the mechanisms for liver fibrosis

by First Hospital of Jilin UniversityHepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. Credit: Wajahat MehalChro

Updated on:May 28,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on: August 30,2024

Study reveals MASLD, MetALD responsible for one-third of ICU cirrhosis cases

by Lori SolomonMetabolic dysfunction-associated steatotic liver disease (MASLD)-related and metabolic and alcohol-related liver disease (MetALD)-related cirrhosis is responsible for one-third of cirrh

Updated on:August 30,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on: August 06,2024

'Treat-all' strategy for patients with chronic hepatitis B virus infection in China: Are we there yet?

by Xia & He Publishing Inc.Graphical Abstract. Credit:Journal of Clinical and Translational Hepatology(2024). DOI: 10.14218/JCTH.2024.00091Chronic hepatitis B (CHB) remains a significa

Updated on:August 06,2024

How Liver Cancer Is Diagnosed

How Liver Cancer Is DiagnosedA biopsy is often not neededByColleen Doherty, MDUpdated on January 03, 2024Medically reviewed byRobert Burakoff, MDLiver cancer(also called&

Updated on: July 01,2024

How Liver Cancer Is Diagnosed

How Liver Cancer Is DiagnosedA biopsy is often not neededByColleen Doherty, MDUpdated on January 03, 2024Medically reviewed byRobert Burakoff, MDLiver cancer(also called&

Updated on:July 01,2024

Overcoming barriers to conducting clinical trials in childhood rare disease research

FEBRUARY 29, 2024byThe Hospital for Sick ChildrenGraphical abstract. Credit:Hepatology(2023). DOI: 10.1097/HEP.0000000000000727Using a novel methodology, researchers at The Hospital

Updated on: March 15,2024

Overcoming barriers to conducting clinical trials in childhood rare disease research

FEBRUARY 29, 2024byThe Hospital for Sick ChildrenGraphical abstract. Credit:Hepatology(2023). DOI: 10.1097/HEP.0000000000000727Using a novel methodology, researchers at The Hospital

Updated on:March 15,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on: June 12,2024

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Updated on:June 12,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024